Citations

Clear

6273 citation(s) found for "To, Andrew".

Representativeness of the American Spine Registry: a comparison of patient characteristics with the National Inpatient Sample
Bydon, Mohamad , Sardar, Zeeshan M. , Michalopoulos, Giorgos D. , Chan, Andrew K. , Norheim, Elizabeth P. , Park, Paul , Ratliff, John K. , Tumialán, Luis M. , Steinmetz, Michael P. , Hsu, Wellington K. , Knightly, John J. , Ziegenhorn, Diane M., Donnelly, Patrick C., Mullen, Kyle , Rykowsky, Stefan, De, Ayushmita , Potts, Eric A. , Coric, Domagoj , Wang, Michael Y. , Qureshi, Sheeraz A. , Sethi, Rajiv K. , Fu, Kai-Ming, Patel, Alpesh A. , Stroink, Ann R., Bisson, Erica F. , Haid, Regis W., Asher, Anthony L. , Burton, Doug , Mummaneni, Praveen V. , Glassman, Steven D. , El Sammak, Sally, Michalopoulos, Giorgos , Ratliff, John , Sammak, Sally El , Carreon, Leah Y. , Pugely, Andrew J. , Yoon, Tim , Brodke, Darrel Scott

Mayo Clinic

Journal of Neurosurgery: Spine | May 6, 2023 | Volume: 39 | Issue: 2 | Pages: 228-237

10.3171/2023.3.spine221264 | PMID 37148235 Get It

OBJECTIVE The American Spine Registry (ASR) is a collaborative effort between the American Academy of Orthopaedic Surgeons and the American Association of Neurological Surgeons. The goal of this study was to evaluate how representative the ASR is of the national practice with spinal procedures, as recorded in the National Inpatient Sample (NIS). METHODS The authors queried the NIS and the ASR for cervical and lumbar arthrodesis cases performed during 2017–2019. International Classification of Diseases, 10th Revision and Current Procedural Terminology codes were used to identify patients undergoing cervical and lumbar procedures. The two groups were compared for the overall proportion of cervical and lumbar procedures, age distribution, sex, surgical approach features, race, and hospital volume. Outcomes available in the ASR, such as patient-reported outcomes and reoperations, were not analyzed due to nonavailability in the NIS. The representativeness of the ASR compared to the NIS was assessed via Cohen’s d effect sizes, and absolute standardized mean differences (SMDs) of < 0.2 were considered trivial, whereas > 0.5 were considered moderately large. RESULTS A total of 24,800 arthrodesis procedures were identified in the ASR for the period between January 1, 2017, and December 31, 2019. During the same time period, 1,305,360 cases were recorded in the NIS. Cervical fusions comprised 35.9% of the ASR cohort (8911 cases) and 36.0% of the NIS cohort (469,287 cases). The two databases presented trivial differences in terms of patient age and sex for all years of interest across both cervical and lumbar arthrodeses (SMD < 0.2). Trivial differences were also noted in the distribution of open versus percutaneous procedures of the cervical and lumbar spine (SMD < 0.2). Among lumbar cases, anterior approaches were more common in the ASR than in the NIS (32.1% vs 22.3%, SMD = 0.22), but the discrepancy among cervical cases in the two databases was trivial (SMD = 0.03). Small differences were illustrated in terms of race, with SMDs < 0.5, and a more significant discrepancy was identified in the geographic distribution of participating sites (SMDs of 0.7 and 0.74 for cervical and lumbar cases, respectively). For both of these measures, SMDs in 2019 were smaller than those in 2018 and 2017. CONCLUSIONS The ASR and NIS databases presented a very high similarity in proportions of cervical and lumbar spine surgeries, as well as similar distributions of age and sex, and distribution of open versus endoscopic approach. Slight discrepancies in anterior versus posterior approach among lumbar cases and patient race, and more significant discrepancies in geographic representation were also identified, yet decreasing trends in differences suggested the improving representativeness of the ASR over the course of time and its progressive growth. These conclusions are important to underline the external validity of quality investigations and research conclusions to be drawn from analyses in which the ASR is used.
Infections in Patients With Left Ventricular Assist Devices: Current State and Future Perspectives
Inglis, Sara S. , Schettle, Sarah , Spencer, Philip J. , Villavicencio, Mauricio A. , Rosenbaum, Andrew , Schettle, Sarah D., Rosenbaum, Andrew N , Inglis, Sara S , Suh, Gina A. , Razonable, Raymund R.

Mayo Clinic

ASAIO Journal | May 5, 2023 | Volume: 69 | Issue: 7 | Pages: 633-641

10.1097/mat.0000000000001956 | PMID 37145863 Get It

Mechanical circulatory support is increasingly being used as bridge-to-transplant and destination therapy in patients with advanced heart failure. Technologic improvements have led to increased patient survival and quality of life, but infection remains one of the leading adverse events following ventricular assist device (VAD) implantation. Infections can be classified as VAD-specific, VAD-related, and non-VAD infections. Risk of VAD-specific infections, such as driveline, pump pocket, and pump infections, remains for the duration of implantation. While adverse events are typically most common early (within 90 days of implantation), device-specific infection (primarily driveline) is a notable exception. No diminishment over time is seen, with event rates of 0.16 events per patient-year in both the early and late periods postimplantation. Management of VAD-specific infections requires aggressive treatment and chronic suppressive antimicrobial therapy is indicated when there is concern for seeding of the device. While surgical intervention/hardware removal is often necessary in prosthesis-related infections, this is not so easily accomplished with VADs. This review outlines the current state of infections in patients supported with VAD therapy and discusses future directions, including possibilities with fully implantable devices and novel approaches to treatment.
Comparison of first-line radiosurgery for small-cell and non-small cell lung cancer brain metastases (CROSS-FIRE)
Rusthoven, Chad G. , Staley, Alyse , Yomo, Shoji , Bernhardt, Denise , Wandrey, Narine , Shafie, Rami A. El , Kraemer, Anna, Padilla, Oscar , Chiang, Veronica , Faramand, Andrew , Wegner, Rodney E. , Hattangadi‐Gluth, Jona A. , Lévy, Antonin , Bernstein, Kenneth , Mathieu, David , Cagney, Daniel , Grills, Inga S., Lee, Cheng-chia, Sheehan, Jason , Kluwe, Christien, Patel, Samir H. , Halasz, Lia M. , Andratschke, Nicolaus , Deibert, Christopher P., Cifarelli, Christopher P. , Debus, Jürgen, Aoyagi, Kyoko , Brown, Paul D. , Alami, Vida, Niranjan, Ajay , Lunsford, L. Dade , Camidge, D Ross, Kavanagh, Brian D. , Serizawa, Toru , Yamamoto, Masaaki, Bernhardt, Denise , Zacharia, Brad E , Andratschke, Nicolaus , Trifiletti, Daniel M , Mathieu, David , Robin, Tyler P. , Gao, Dexiang , Palmer, Joshua D. , Zacharia, Brad E. , Chan, Michael David , Braunstein, Steve , Verma, Vivek, Trifiletti, Daniel M. , Combs, Stephanie Elisabeth , Sato, Yasunori , Higuchi, Yoshinori , Kondziolka, Douglas

Mayo Clinic

JNCI: Journal of the National Cancer Institute | May 4, 2023 | Volume: 115 | Issue: 8 | Pages: 926-936

10.1093/jnci/djad073 | PMID 37142267 Get It

Abstract Introduction Historical reservations regarding stereotactic radiosurgery (SRS) for small-cell lung cancer (SCLC) brain metastases include concerns for short-interval and diffuse central nervous system (CNS) progression, poor prognoses, and increased neurological mortality specific to SCLC histology. We compared SRS outcomes for SCLC and non-small cell lung cancer (NSCLC) where SRS is well established. Methods Multicenter first-line SRS outcomes for SCLC and NSCLC from 2000 to 2022 were retrospectively collected (n = 892 SCLC, n = 4785 NSCLC). Data from the prospective Japanese Leksell Gamma Knife Society (JLGK0901) clinical trial of first-line SRS were analyzed as a comparison cohort (n = 98 SCLC, n = 814 NSCLC). Overall survival (OS) and CNS progression were analyzed using Cox proportional hazard and Fine-Gray models, respectively, with multivariable adjustment for cofactors including age, sex, performance status, year, extracranial disease status, and brain metastasis number and volume. Mutation-stratified analyses were performed in propensity score–matched retrospective cohorts of epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) positive NSCLC, mutation-negative NSCLC, and SCLC. Results OS was superior for patients with NSCLC compared to SCLC in the retrospective dataset (median OS = 10.5 vs 8.6 months; P &lt; .001) and in the JLGK0901 dataset. Hazard estimates for first CNS progression favoring NSCLC were similar in both datasets but reached statistical significance in the retrospective dataset only (multivariable hazard ratio = 0.82, 95% confidence interval = 0.73 to 0.92, P = .001). In the propensity score–matched cohorts, there were continued OS advantages for NSCLC patients (median OS = 23.7 [EGFR and ALK positive NSCLC] vs 13.6 [mutation-negative NSCLC] vs 10.4 months [SCLC], pairwise P values &lt; 0.001), but no statistically significant differences in CNS progression were observed in the matched cohorts. Neurological mortality and number of lesions at CNS progression were similar for NSCLC and SCLC patients. Leptomeningeal progression was increased in patients with NSCLC compared to SCLC in the retrospective dataset only (multivariable hazard ratio = 1.61, 95% confidence interval = 1.14 to 2.26, P = .007). Conclusions After SRS, SCLC histology was associated with shorter OS compared to NSCLC. CNS progression occurred earlier in SCLC patients overall but was similar in patients matched on baseline factors. SCLC was not associated with increased neurological mortality, number of lesions at CNS progression, or leptomeningeal progression compared to NSCLC. These findings may better inform clinical expectations and individualized decision making regarding SRS for SCLC patients.
A Novel Spectral Index for Tracking Preload Change from a Wireless, Wearable Doppler Ultrasound
Kenny, Jon‐Émile S. , Yang, Zhen , Elfarnawany, Mai , Munding, Chelsea E. , Eibl, Andrew M., Eibl, Joseph K. , Taylor, Jenna L. , Kim, Chul‐Ho , Johnson, Bruce D. , Elfarnawany, Mai , Taylor, Jenna L , Kim, Chul-Ho , Clarke, Geoffrey

Mayo Clinic

Diagnostics | May 1, 2023 | Volume: 13 | Issue: 9 | Pages: 1590

10.3390/diagnostics13091590 | PMID 37174981 Get It

A wireless, wearable Doppler ultrasound offers a new paradigm for linking physiology to resuscitation medicine. To this end, the image analysis of simultaneously-acquired venous and arterial Doppler spectrograms attained by wearable ultrasound represents a new source of hemodynamic data. Previous investigators have reported a direct relationship between the central venous pressure (CVP) and the ratio of the internal jugular-to-common carotid artery diameters. Because Doppler power is directly related to the number of red cell scatterers within a vessel, we hypothesized that (1) the ratio of internal jugular-to-carotid artery Doppler power (V/APOWER) would be a surrogate for the ratio of the vascular areas of these two vessels and (2) the V/APOWER would track the anticipated CVP change during simulated hemorrhage and resuscitation. To illustrate this proof-of-principle, we compared the change in V/APOWER obtained via a wireless, wearable Doppler ultrasound to B-mode ultrasound images during a head-down tilt. Additionally, we elucidated the change in the V/APOWER during simulated hemorrhage and transfusion via lower body negative pressure (LBNP) and release. With these Interesting Images, we show that the Doppler V/APOWER ratio qualitatively tracks anticipated changes in CVP (e.g., cardiac preload) which is promising for both diagnosis and management of hemodynamic unrest.
Somatic Mutations of MUC5B Within Lung Tissue in Idiopathic Pulmonary Fibrosis
Khan, Mehnaz, Krone, Katie A. , Hobbs, B.D. , Hersh, C.P. , Barwick, Lucas, Flaherty, K.R., Brown, Kevin K. , Wise, R.A.A., Martinez, F.J., Silverman, E.K., DeMeo, Dawn L. , Cho, M.H., Bick, Alex, Yun, Jeong H. , Ghosh, Auyon , Castaldi, Peter J. , Miller, P., Sciurba, Frank C. , Limper, Andrew H. , Flaherty, K.R., Criner, Gerard J. , Cho, M.H.

Mayo Clinic

A16. INTERROGATING GENOMIC, TRANSCRIPTIONAL, AND EPIGENETIC MECHANISMS IN LUNG FIBROSIS | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A1036-A1036

10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1036 Get It

Whole Genome Sequencing Analysis of Mucus Plugging in Chronic Obstructive Pulmonary Disease (COPD)
Medicine, Trans-Omics in Precision, Silverman, E.K., Nath, H.P., Orejas, J. , Yen, Andrew , Jacobs, Kathleen, Manapragada, Padma P. , Abozeed, Mostafa , Zahid, Mohd , Sonavane, Sushilkumar K. , Cho, M.H. , Kim, Katherine Callaway , Grumley, Scott , Dolliver, Wojciech Remington , Yen, A., Aziz, Muhammad Usman , Díaz, Alejandro A.

Mayo Clinic

A24. COPD PHENOTYPES: LOOKING OUTSIDE THE LUNG | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A1153-A1153

10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1153 Get It

Targeting RAD51 for the Treatment of Pulmonary Fibrosis
Choudhury, M., Schaefbauer, Kyle, Limper, Andrew H.

Mayo Clinic

D19. NEW PERSPECTIVES ON TRANSLATIONAL STUDIES FOR LUNG FIBROSIS | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A6260-A6260

10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a6260 Get It

Matricellular Protein CCN3 as a Target to Promote Lung Endothelial Homeostasis and Repair in the Fibrotic Lung
Betageri, K.R., Haak, Andrew J. , Ligresti, Giovanni , Tschumperlin, Daniel J. , Link, Patrick A. , Caporarello, Nunzia

Mayo Clinic

A66. DISSECTING THE MATRIX AND MESENCHYMAL CELLS IN FIBROSIS | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A2192-A2192

10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2192 Get It

Inclusion of Comorbidities and Prognosis in U.S. States' Triage Plans During COVID-19
Ennis, Jackson S, Nguyen, N.V. , Kramer, D.B., Smith, Andrew , Sulmasy, Dan, Tilburt, Jon C. , DeMartino, Erin S. , Ennis, Jackson S. , Riggan, Kirsten A. , Wolf, Susan M.

Mayo Clinic

D93. CLINICAL AND TRANSLATIONAL STUDIES OF COVID-19 CRITICAL ILLNESS | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A6554-A6554

10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a6554 Get It